RNS Hotlist with Zak Mir: GGP, GLR, ALL, IUG, TM1, HUI, ORPH, OKYO, NSCI, PREM & RBD via Vox Markets

Greatland Gold (GGP), a mining development and exploration company, announced it has been awarded a grant from the Western Australian Government to co-fund exploration drilling and mobilisation costs at its 100% owned Ernest Giles exploration project.

Author @ZaksTradersCafe

The company said this drilling grant award (£120,000) for the Ernest Giles project will co-fund commencement of a new exploration programme. Ernest Giles is located in the Yilgarn craton, one of the most highly mineralised areas in the world and home to numerous gold deposits.

Galileo Resources (GLR) announced that JSE listed Afrimat Limited has given notice to Glenover Phosphate Proprietary Limited in which Galileo now has a 30.7% direct and 4.99% indirect investment held via Galagen Proprietary Limited who is the BEE partner in Glenover, that Afrimat wish to conditionally acquire 100% of the shares in Glenover from the current shareholders of Glenover for consideration of ZAR300 million (approximately GBP14.6 million). GLR said it was very pleased that the Afrimat Board has decided to proceed with the Glenover Acquisition. Upon completion of the Glenover Acquisition the Company’s share of the Glenover Consideration will be approximately £5.2 million.

Atlantic Lithium (ALL), the funded African-focussed lithium exploration and development company, announced assay results from the resource and exploration drilling programme now completed at the Ewoyaa Lithium Project. The company said the programme was increased by an additional 10,000m, to a total of 47,000m, which included detailed geotechnical, metallurgical, hydrogeological, resource and exploration drilling.

Intelligent Ultrasound (IUG), the ‘classroom to clinic’ ultrasound company, announced that the FDA has granted De Novo clearance for clinical use of its AI medical device, ScanNav Anatomy Peripheral Nerve Block in the USA. The ScanNav Anatomy PNB product can now be launched into the USA anaesthesiology ultrasound market.

Technology Minerals (TM1) has announced the results of the first work programme on new Prospecting Licence Area (PLA 1597) in County Wexford, Republic of Ireland, has yielded high-grade spodumene pegmatite samples in float ranging up to 2.95% Li2O. The licence will form part of the Company’s Leinster Property exploration block, which is operated under an exclusive Option and Earn-in agreement with Global Battery Metals Ltd with no project expenditure required by the Company.

Hydrogen Utopia (HUI) announced that it has entered into a convertible loan facility with Conrad Griffiths as lender in respect of an advance of EUR 650,000. Conrad Griffiths currently owns 9.45% of the ordinary share capital of the Company. The company said that as a substantial shareholder, Mr Griffiths, a King’s Counsel barrister based in Turks and Caicos which is a US$ based economy, is keen to see the rapid development of HUI’s business.

Open Orphan (ORPH), (to be renamed hVIVO (HVO) effective 26 October 2022), a contract research organisation announced that it will be holding a Capital Markets Day for analysts, institutional investors and media on Wednesday 2 November 2022 at 9.30 am – 12.00 pm (GMT). The event, which will be chaired by CEO Yamin ‘Mo’ Khan.

OKYO Pharma (OKYO), an ophthalmology-focused bio-pharmaceutical company, said it will be participating in The ThinkEquity Conference, which will take place on October 26, 2022 at The Mandarin Oriental Hotel in New York.

NetScientific (NSCI), the active international holding company, announced that its subsidiary EMV Capital has led and advised on a £2.5m investment round in domestic heat efficiency champion Ventive, and has taken a c.16% equity stake in partial settlement of fees and in line with its capital light investment model.

Premier African Minerals (PREM) reported on assay results at Premier’s Zulu Lithium and Tantalum Project. These results are from boreholes that constitute part of the Mineral Resource update required to support the DFS. The company said all indications point to the mineralisation being almost exclusively spodumene with little to no petalite and equally low contained micaceous mineralisation carrying any lithium.

Reabold (RBD) said it had received a letter from Pershing Nominees Limited, which owns approximately 6.93% of the Company’s issued share capital on behalf of five beneficial shareholders, requesting the Board to convene a general meeting under section 303 of the Companies Act 2006. The Board was advised that the requisition letter contained several deficiencies, including the potential for resolutions to be voted on in such a combination that the Company could be left without a minimum of two directors.

Author @ZaksTradersCafe

Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.

Linking Shareholders and Executives :Share Talk

If anyone reads this article found it useful, helpful? Then please subscribe www.share-talk.com or follow SHARE TALK on our Twitter page for future updates. Terms of Website Use All information is provided on an as-is basis. Where we allow Bloggers to publish articles on our platform please note these are not our opinions or views and we have no affiliation with the companies mentioned

Weekly Newsletter

Sign up to receive exclusive stock market content in your inbox, once a week.

We don’t spam! Read our privacy policy for more info.